Elutia Inc. (ELUT)
NASDAQ: ELUT · Real-Time Price · USD
4.380
+0.170 (4.04%)
Nov 20, 2024, 4:00 PM EST - Market closed
Elutia Revenue
Elutia had revenue of $5.92M in the quarter ending September 30, 2024, a decrease of -3.35%. This brings the company's revenue in the last twelve months to $24.78M, down -2.65% year-over-year. In the year 2023, Elutia had annual revenue of $24.75M with 3.76% growth.
Revenue (ttm)
$24.78M
Revenue Growth
-2.65%
P/S Ratio
6.11
Revenue / Employee
$458,926
Employees
54
Market Cap
149.18M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Puma Biotechnology | 243.57M |
Pro-Dex | 56.80M |
Sensus Healthcare | 41.31M |
Vaxart | 16.76M |
Seer, Inc. | 14.61M |
Akso Health Group | 2.41M |
ELUT News
- 6 days ago - Elutia Inc. (ELUT) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Elutia to Present at the LD Micro Main Event XVII Conference on Wednesday, October 30 - GlobeNewsWire
- 2 months ago - Elutia Announces New Peer Reviewed Publication Highlighting the Robustness of EluPro™, Company's Antibiotic-Eluting BioEnvelope for Implantable Devices - GlobeNewsWire
- 2 months ago - Elutia Celebrates First Year - GlobeNewsWire
- 2 months ago - Elutia Announces First Patient Implant of EluPro™, the World's First Drug-Eluting BioEnvelope for Cardiac Pacemakers and Neurostimulators - GlobeNewsWire
- 2 months ago - Elutia to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now - GlobeNewsWire
- 3 months ago - Elutia Inc. (ELUT) Q2 2024 Earnings Call Transcript - Seeking Alpha